Phibro Animal Health Corporation - (PAHC): Price and Financial Metrics

Phibro Animal Health Corporation - (PAHC)

Today's Latest Price: $21.25 USD

0.07 (-0.33%)

Updated Jan 22 4:00pm

Add PAHC to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 77 in Medical - Services

See all "A" rated Strong Buy stocks

PAHC Stock Summary

  • Phibro Animal Health Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 89.43% of US listed stocks.
  • PAHC's went public 6.79 years ago, making it older than just 24.86% of listed US stocks we're tracking.
  • Of note is the ratio of Phibro Animal Health Corp's sales and general administrative expense to its total operating expenses; 88.08% of US stocks have a lower such ratio.
  • Stocks that are quantitatively similar to PAHC, based on their financial statements, market capitalization, and price volatility, are PRIM, ARC, KRO, CRI, and SGMA.
  • Visit PAHC's SEC page to see the company's official filings. To visit the company's web site, go to

PAHC Stock Price Chart Interactive Chart >

Price chart for PAHC

PAHC Price/Volume Stats

Current price $21.25 52-week high $29.38
Prev. close $21.32 52-week low $16.27
Day low $21.01 Volume 89,800
Day high $21.40 Avg. volume 121,793
50-day MA $19.47 Dividend yield 2.26%
200-day MA $21.40 Market Cap 859.63M

Phibro Animal Health Corporation - (PAHC) Company Bio

Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company was founded in 2000 and is based in Teaneck, New Jersey.

PAHC Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$21.25$17.33 -19%

We started the process of determining a valid price forecast for Phibro Animal Health Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Phibro Animal Health Corp ranked in the 46th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 18.33%. In terms of the factors that were most noteworthy in this DCF analysis for PAHC, they are:

  • The company's balance sheet shows it gets 68% of its capital from equity, and 32% of its capital from debt. Notably, its equity weight is greater than only 18.59% of US equities in the Healthcare sector yielding a positive free cash flow.
  • Phibro Animal Health Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 7.31% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Phibro Animal Health Corp? See INBP, IQV, LMAT, BDX, and LCI.

PAHC Latest News Stream

Event/Time News Detail
Loading, please wait...

PAHC Latest Social Stream

Loading social stream, please wait...

View Full PAHC Social Stream

Latest PAHC News From Around the Web

Below are the latest news stories about Phibro Animal Health Corp that investors may wish to consider to help them evaluate PAHC as an investment opportunity.

PAHC vs. SRDX: Which Stock Should Value Investors Buy Now?

PAHC vs. SRDX: Which Stock Is the Better Value Option?

Yahoo | January 20, 2021

Phirbo (PAHC) Nutritional Specialty Aids Growth, Low ASP Ails

Phirbo's (PAHC) net vaccine sales remain robust on higher international demand for poultry vaccines.

Yahoo | January 12, 2021

Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2020 Quarterly Financial Results

Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 3, 2021, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 4, 2021 at 9:00 AM Eastern Time.

Yahoo | January 5, 2021

TULISSIN® 100 Brand of Tulathromycin Now Approved by Health Canada

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health will represent and market Virbac’s newly approved TULISSIN® 100 brand of tulathromycin.

Business Wire | December 29, 2020

Why Phibro Animal Health Corporation (NASDAQ:PAHC) Looks Like A Quality Company

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Yahoo | December 25, 2020

Read More 'PAHC' Stories Here

PAHC Price Returns

1-mo N/A
3-mo 19.15%
6-mo -9.78%
1-year -14.21%
3-year -37.63%
5-year -27.97%
YTD 9.42%
2020 -20.09%
2019 -21.31%
2018 -3.00%
2017 15.75%
2016 -1.16%

PAHC Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PAHC Dividend History

Continue Researching PAHC

Here are a few links from around the web to help you further your research on Phibro Animal Health Corp's stock as an investment opportunity:

Phibro Animal Health Corp (PAHC) Stock Price | Nasdaq
Phibro Animal Health Corp (PAHC) Stock Quote, History and News - Yahoo Finance
Phibro Animal Health Corp (PAHC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8211 seconds.